Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety

By Yadav Rahul   France Michael   Younis Naveed   Hama Salam   Ammori Basil J   Kwok See   Soran Handrean  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1345-1362

Informa Healthcare

Access to resources Recommend Favorite

An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability

By Crouse John R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 3, 2008-03 ,pp. : 287-304

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia – A Phase 3 Study

By Roth Eli   Rosenson Robert   Carlson Dawn   Fukumoto Sandra   Setze Carolyn   Blasetto James   Khurmi Nardev   Stolzenbach James   Williams Laura  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 421-428

Springer Publishing Company

Access to resources Recommend Favorite

One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia: Evaluation of Dose Response

By Ferdinand Keith C.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite

Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety

By Kothare Sanjeev V   Kaleyias Joseph  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 4, 2008-04 ,pp. : 493-506

Informa Healthcare

Access to resources Recommend Favorite